LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's long-term debt is $5.5M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), LFMDP shows a long-term debt of $5.5M. That compares with $13M in the prior-year period — down 57.7% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, LFMDP's long-term debt is now $5.5M (was $13M) — a 57.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A is outperforming or lagging.
Tracking LFMDP's long-term debt over time shows whether LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A is scaling, shrinking, or reshaping that part of the business. The current reading is $5.5M That compares with $13M in the prior-year period — down 57.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $5.5M) with ownership activity and broader fundamentals.
LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's long-term debt is $5.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.